Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionQuadrant Capital Group Llc
Latest Disclosed Ownership2,423 shares
Latest Disclosed Value $ 126,626
Quadrant Capital Group Llc reports 5.61% decrease in ownership of TECH / Bio-Techne Corporation

On May 13, 2026 - Quadrant Capital Group Llc filed a 13F-HR/A form disclosing ownership of 2,423 shares of Bio-Techne Corporation (US:TECH) valued at $126,626 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 2,567 shares of Bio-Techne Corporation. This represents a change in shares of -5.61% during the quarter. The current value of the position is $123,210 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 BIO-TECHNE COM 09073M104 2,423 -144 -5.61 127 -16.00 0.0038
2026-05-11 2026-03-31 13F BIO-TECHNE COM 09073M104 2,423 -144 49 0.0369
2026-02-12 2025-12-31 13F BIO-TECHNE COM 09073M104 2,567 1,645 178.42 151 194.12 0.0046
2025-11-13 2025-09-30 13F BIO-TECHNE COM 09073M104 922 922 51 0.0017
2025-08-13 2025-06-30 13F BIO-TECHNE COM 09073M104 0 -3,850 -100.00 0 -100.00
2025-05-13 2025-03-31 13F BIO-TECHNE COM 09073M104 3,850 2,704 235.95 226 174.39 0.0084
2025-02-13 2024-12-31 13F BIO-TECHNE COM 09073M104 1,146 -312 -21.40 83 -29.31 0.0057
2024-11-12 2024-09-30 13F BIO-TECHNE COM 09073M104 1,458 -3 -0.21 117 11.54 0.0081
2024-08-12 2024-06-30 13F BIO-TECHNE COM 09073M104 1,461 38 2.67 105 4.00 0.0078
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 1,423 303 27.05 100 16.28 0.0079
2024-02-08 2023-12-31 13F BIO-TECHNE COM 09073M104 1,120 323 40.53 86 59.26 0.0074
2023-11-14 2023-09-30 13F BIO-TECHNE COM 09073M104 797 -464 -36.80 54 -47.06 0.0054
2023-08-10 2023-06-30 13F BIO-TECHNE COM 09073M104 1,261 -63 -4.76 103 4.08 0.0102
2023-05-11 2023-03-31 13F BIO-TECHNE COM 09073M104 1,324 -232 -14.91 98 -23.44 0.0102
2023-02-13 2022-12-31 13F BIO-TECHNE COM 09073M104 1,556 1,132 266.98 129 6.67 0.0146
2022-11-10 2022-09-30 13F BIO-TECHNE COM 09073M104 424 93 28.10 120 4.35 0.0159
2022-08-09 2022-06-30 13F BIO-TECHNE COM 09073M104 331 -32 -8.82 115 -26.75 0.0154
2022-05-06 2022-03-31 13F BIO-TECHNE COM 09073M104 363 39 12.04 157 -6.55 0.0190
2022-02-01 2021-12-31 13F BIO-TECHNE COM 09073M104 324 93 40.26 168 50.00 0.0200
2021-11-12 2021-09-30 13F BIO-TECHNE COM 09073M104 231 29 14.36 112 23.08 0.0156
2021-08-09 2021-06-30 13F BIO-TECHNE COM 09073M104 202 -18 -8.18 91 8.33 0.0132
2021-05-12 2021-03-31 13F BIO-TECHNE COM 09073M104 220 23 11.68 84 33.33 0.0136
2021-02-16 2020-12-31 13F BIO-TECHNE COM 09073M104 197 4 2.07 63 31.25 0.0117
2020-11-13 2020-09-30 13F BIO-TECHNE COM 09073M104 193 -337 -63.58 48 -65.71 0.0105
2020-08-13 2020-06-30 13F BIO-TECHNE COM 09073M104 530 301 131.44 140 225.58 0.0310
2020-05-15 2020-03-31 13F Bio-Techne Com 09073M104 229 182 387.23 43 377.78 0.0072
2020-03-19 2019-12-31 13F/A-1 Bio-Techne Com 09073M104 47 0 0.00 9 12.50 0.0011
2020-02-03 2019-12-31 13F Bio-Techne Com 09073M104 47 0 9 30.4122
2019-10-24 2019-09-30 13F Bio-Techne COM 09073M104 47 -236 -83.39 8 -85.71 0.0012
2019-07-24 2019-06-30 13F Bio-Techne COM 09073M104 283 0 0.00 56 3.70 0.0089
2019-04-29 2019-03-31 13F Bio-Techne COM 09073M104 283 236 502.13 54 800.00 0.0095
2019-01-17 2018-12-31 13F BIO-TECHNE COM 09073M104 47 0 0.00 6 -25.00 0.0016
2018-10-29 2018-09-30 13F BIO-TECHNE COM 09073M104 47 0 0.00 8 33.33 0.0023
2018-08-08 2018-06-30 13F BIO-TECHNE COM 09073M104 47 0 0.00 6 0.00 0.0021
2018-05-10 2018-03-31 13F BIO-TECHNE COM 09073M104 47 0 0.00 6 20.00 0.0022
2018-01-31 2017-12-31 13F Bio-Techne COM 09073M104 47 -69 -59.48 5 -58.33 0.0020
2017-10-13 2017-09-30 13F Bio-Techne COM 09073M104 116 16 16.00 12 20.00 0.0050
2017-08-14 2017-06-30 13F Bio-Techne COM 09073M104 100 17 20.48 10 25.00 0.0044
2017-04-10 2017-03-31 13F Bio-Techne COM 09073M104 83 0 0.00 8 0.00 0.0035
2017-01-11 2016-12-31 13F Bio-Techne COM 09073M104 83 0 0.00 8 0.00 0.0040
2016-10-25 2016-09-30 13F Bio-Techne COM 09073M104 83 0 0.00 8 0.00 0.0052
2016-07-28 2016-06-30 13F Bio-Techne COM 09073M104 83 8 10.67 8 14.29 0.0055
2016-04-27 2016-03-31 13F Bio-Techne COM 09073M104 75 0 0.00 7 16.67 0.0045
2016-01-28 2015-12-31 13F Bio-Techne COM 09073M104 75 -415 -84.69 6 -86.36 0.0042
2015-10-28 2015-09-30 13F Bio-Techne COM 09073M104 490 -10 -2.00 44 -8.33 0.0304
2015-08-12 2015-06-30 13F Bio-Techne COM 09073M104 500 500 48 0.0305
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.